Polarean

medical devices

About

Polarean Imaging Plc is a medical imaging technology company based in London, UK, focused on enhancing pulmonary medicine through advanced MRI technology. Founded in 2011, Polarean operates internationally, including in the United States. The company specializes in developing hyperpolarized MRI contrast agents and related drug-device combination products that enable non-invasive, radiation-free imaging of lung function. The flagship product, XENOVIEW™, is the first FDA-approved hyperpolarized xenon-129 MRI contrast agent. It allows for detailed visualization of ventilation, gas exchange, and pulmonary vasculature in the lungs, addressing the needs of over 500 million patients with chronic respiratory diseases. Polarean also offers gas polarizer devices, MRI radiofrequency coils compatible with major MRI systems, and ancillary instruments to support biomedical imaging research and clinical applications. Polarean's strategy includes fostering research collaborations and facilitating clinical adoption to enhance the market presence of XENOVIEW and its technologies, targeting healthcare providers and researchers in the field of pulmonary medicine.

Technologies

Outlook WordPress.org Vimeo Wistia Google Font API Google Tag Manager Mobile Friendly IoT Remote AI

Keywords

hyperpolarized gases xenon polarizer pulmonary imaging hyperpolarized gas mri helium polarizer functional lung imaging xenon hyperpolarizer helium hyperpolarizer ild pulmonary hypertension cystic fibrosis ipf copd interventional pulmonology asthma medical equipment manufacturing lung health hyperpolarization technology lung function imaging hyperpolarized gas lung disease therapy evaluation lung ventilation imaging lung imaging lung disease diagnostics manufacturing b2b lung imaging innovation mri technology gas polarization hyperpolarized noble gases

Location

2500 Meridian Pkwy, Durham, North Carolina, United States, 27713-4209

Related Companies

Companies in the same industry